CALZARI, PAOLO
CALZARI, PAOLO
Universita' degli Studi di MILANO
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence
2026 F. Barei, P. Calzari, S. Macchi, S. Ribero, M. Ortoncelli, C. Foti, A. Balato, E.V. Di Brizzi, K. Peris, N. Gori, E. De Luca, C. Gurioli, B.M. Piraccini, E. Pezzolo, L. Bonzano, E. Errichetti, N. Schettini, E. Nettis, M. Gola, N. Milanesi, C. Feliciani, M.B. De Felici Del Giudice, F. Caroppo, A. Belloni Fortina, A. Campanati, H. Gioacchini, F. Manzo Margiotta, M. Romanelli, K. Hansel, L. Stingeni, L. Calabrese, P. Rubegni, L. Lazzeri, L. Grigolato, B. Galli, M. Rossi, M. Maurelli, G. Girolomoni, L. Coronella, C. Patruno, M. Napolitano, A. Alfano, L. Gargiulo, A. Narcisi, A.V. Marzano, S.M. Ferrucci
Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center
2026 A. Chiei Gallo, G. Tavoletti, D. Termini, G. Avallone, F. Barei, P. Calzari, R. Pinto, A.V. Marzano, S.M. Ferrucci
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area
2026 G. Avallone, F.M. Margiotta, A. Bombelli, L. Gargiulo, C. Foti, I. Trave, M. Rossi, E. Magnaterra, F. Pigliacelli, P. Malagoli, S. Giacalone, A. Portarapillo, C. Patruno, N. Schettini, L. Bonzano, E. Pezzolo, C. Chello, N. Gori, G. Brunasso, F. Veronese, M. Ortoncelli, E. Tolino, A. Azzolini, F. Bellinato, K. Hansel, E.V. Di Brizzi, C. Gurioli, M. Esposito, R. Giuffrida, F. Barei, P. Calzari, A.G. Burroni, M. Gola, M. Mariano, M.C. Fargnoli, M. Napolitano, T. Grieco, K. Peris, P. Savoia, S. Ribero, G. Girolomoni, L. Stingeni, A. Balato, A. Costanzo, A.V. Marzano, A. Narcisi, S.M. Ferrucci
Patch test sensitization and permanent tattoos: epidemiological data from two referral centers
2026 A. Chiei Gallo, F. Barei, C.P. Ratti, E. Bono, A. Botta, M. Cavara, P. Calzari, E. Rusconi, L. Caron, A.V. Marzano, V.G.R. Ortolani, E. Iemoli, S.M. Ferrucci
Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck Involvement
2026 L. Gargiulo, L. Ibba, M. Bianco, S. Di Giulio, M. Valenti, G. Avallone, M. Zussino, P. Calzari, A.V. Marzano, A. Costanzo, S.M. Ferrucci, A. Narcisi
Exercise-induced vasculitis with histological and genetic evidence of complement involvement
2026 M. Cugno, P. Calzari, A.D. Benedetto, F.L. Boggio, C. Moltrasio, L. Porcaro, A.V. Marzano
Severe chronic spontaneous urticaria responding and not responding to omalizumab: analysis of the prognostic value of known and novel in vitro variables
2026 R. Asero, P. Calzari, S. Ferrucci, M. Lorini, V. Carbonelli, S. Stella, D. Consonni, M. Cugno
Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria
2026 P. Calzari, E.M. Favale, M. Cugno, R. Asero, A.V. Marzano, S.M. Ferrucci
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series
2026 F. Barei, P. Calzari, G. Avallone, M. Zussino, A.V. Marzano, S.M. Ferrucci
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
2025 A. Chiei Gallo, G. Tavoletti, G. Avallone, E. Bono, F. Barei, P. Calzari, A.V. Marzano, S.M. Ferrucci
Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes
2025 F. Barei, P. Calzari, E. Pezzolo, M. Napolitano, M. Rossi, M.B. Guanti, F. Caroppo, A. Belloni Fortina, C. Patruno, A. Campanati, T. Bianchelli, G.M. D'Agostino, E. Nettis, F. Pugliese, F. Di Vico, I. Trave, E. Cozzani, L. Stingeni, K. Hansel, M. Dall'Olio, L. Grigolato, R. Coppola, V. Panasiti, M. Maurelli, G. Girolomoni, M. Ortoncelli, S. Ribero, A.V. Marzano, S.M. Ferrucci
Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study
2025 A. Chiei-Gallo, F. Barei, P. Calzari, A. Pisapia, A.V. Marzano, S.M. Ferrucci
Three-year observational study on the long-term efficacy and safety of dupilumab in elderly patients with severe atopic dermatitis
2025 A. Chiei-Gallo, F. Barei, P. Calzari, A. Pisapia, A.V. Marzano, S.M. Ferrucci
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis
2025 G. Avallone, A. Bombelli, L. Valtellini, G. Tavoletti, B. Galli, M. Rossi, M. Maurelli, G. Girolomoni, L. Gargiulo, A. Narcisi, F. Di Vico, M. Napolitano, L. Lazzeri, L. Calabrese, S. Caccavale, A. Balato, F. Barei, P. Calzari, C. Foti, I. Trave, E. Cozzani, F. Rongioletti, S. Lenti, C. Gurioli, E. Nettis, F. Caroppo, E. Errichetti, L. Bonzano, N. Gori, K. Peris, S. Lembo, L. Del Regno, M. Esposito, M.C. Fargnoli, P. Savoia, E. Esposto, R. Giuffrida, F. Guarneri, C. Patruno, E. Pezzolo, L. Stingeni, K. Hansel, L. Mastorino, M. Ortoncelli, S. Ribero, A.V. Marzano, S.M. Ferrucci
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres
2025 G. Tavoletti, A. Chiei-Gallo, L. Gargiulo, G. Avallone, L. Ibba, F. Barei, P. Calzari, A. Narcisi, A.V. Marzano, S.M. Ferrucci
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience
2025 F. Barei, P. Calzari, E. Pezzolo, M. Napolitano, M. Rossi, M.B. Guanti, F. Caroppo, A. Belloni Fortina, C. Patruno, A. Campanati, T. Bianchelli, G.M. D'Agostino, E. Nettis, F. Pugliese, V. Picone, I. Trave, E. Cozzani, L. Stingeni, K. Hansel, M. Dall'Olio, B. Galli, R. Coppola, V. Panasiti, M. Maurelli, G. Girolomoni, M. Ortoncelli, S. Ribero, A.V. Marzano, S. Ferrucci
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
2024 P. Calzari, A. Chiei Gallo, F. Barei, E. Bono, M. Cugno, A.V. Marzano, S.M. Ferrucci
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
2024 F. Barei, P. Calzari, L. Valtellini, A. Chiei Gallo, G. Perego, S. Tavecchio, M. Zussino, A.V. Marzano, S. Ferrucci
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
2024 R. Asero, P. Calzari, S. Vaienti, M. Cugno
Contact system activation and bradykinin generation in patients with idiopathic angioedema
2024 C. Suffritti, P. Calzari, F. Depetri, S. Griffini, E. Grovetti, R. Santacroce, M. Margaglione, M. Cugno